Tumore dell'endometrio - Ematologia oncologica

from Salute e Società · host Marco Caracciolo

1. L'Aifa ha approvato una nuova terapia, a base di un farmaco monoclonale, dostarlimab, prima immunoterapia per le pazienti con malattia ricorrente e avanzata. 2. Disponibile in Italia nuova formulazione di ibrutinib, inibitore della tirosin chinasi di Bruton, come monosomministrazione giornaliera.

Episode metadata supplied by the publisher feed · Published Oct 25, 2022

Embed this episode

Attribution link and audio player

NOW PLAYING

Tumore dell'endometrio - Ematologia oncologica

0:00 5:56

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

DECODIFICAMOS EL MENSAJE DE AVI LOEB. ¿PODRÍA SER UNA NAVE ALIENÍGENA? CON BARTHÉLEMY D'ANS

Nov 2, 2025 ·183m

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Salute e Società?

This episode is 5 minutes long.

When was this Salute e Società episode published?

This episode was published on October 25, 2022.

Can I download this Salute e Società episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!